Accordingly, CD8+GZMK+ and CD4+GZMK+ T cells are enriched at sites of chronic inflammation in the context of autoimmune diseases and tumors likely contributing to chronicity, tumor immune escape, outgrowth and metastasis. The gene discussed is CD4; the disease is neoplasm.